share_log

美诺华(603538.SH):全资子公司获得硫酸氨基葡萄糖胶囊药品注册证书

Ningbo Menovo Pharmaceutical (603538.SH): Wholly-owned subsidiary obtained pharmaceutical registration certificate for ammonium sulfate glucosamine capsules.

Gelonghui Finance ·  Jun 25 05:03

Ningbo Menovo Pharmaceutical, a wholly-owned subsidiary of Menovo Pharmaceutical (603538.SH), announced on June 25th that it has recently received the Drug Registration Certificate for Glucosamine Sulfate Capsules from the National Medical Products Administration. The drug is used for the treatment of primary and secondary osteoarthritis.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment